At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
Torax Medical, Inc. LINX Reflux Management Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter
In Brief
A clinical study evaluating Torax Medical, Inc. LINX Reflux Management System for Gastroesophageal Reflux Disease. Completed, enrolled 44 participants across 5 sites in 3 countries.
Detailed Summary
Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux Disease
CountriesItaly, Netherlands, United States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2007
Primary CompletionJul 2009
First PostedJan 2010
Study CompletionAug 2013
TodayJul 2026
First PostedJan 28, 2010
Enrollment StartFeb 1, 2007
Primary CompletionJul 1, 2009
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 16.4 years ago
Interventions
Torax Medical, Inc. LINX Reflux Management Systemdevice
Implantable device, Magnetic Esophageal Sphincter